Integrated Advisors Network LLC reduced its stake in Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 45.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,334 shares of the company’s stock after selling 1,927 shares during the period. Integrated Advisors Network LLC’s holdings in Addus HomeCare were worth $231,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also made changes to their positions in ADUS. Capital Research Global Investors bought a new stake in Addus HomeCare during the fourth quarter worth $51,149,000. American Century Companies Inc. lifted its stake in Addus HomeCare by 695.8% during the fourth quarter. American Century Companies Inc. now owns 284,346 shares of the company’s stock worth $35,643,000 after purchasing an additional 248,613 shares during the last quarter. GAMMA Investing LLC lifted its stake in Addus HomeCare by 10,307.8% during the first quarter. GAMMA Investing LLC now owns 130,930 shares of the company’s stock worth $12,948,000 after purchasing an additional 129,672 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of Addus HomeCare by 273.6% in the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company’s stock valued at $21,945,000 after acquiring an additional 128,211 shares during the last quarter. Finally, TimesSquare Capital Management LLC boosted its holdings in shares of Addus HomeCare by 28.5% during the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after acquiring an additional 78,835 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several equities analysts have commented on ADUS shares. Wall Street Zen downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Stephens restated an “overweight” rating and set a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. Macquarie restated an “outperform” rating and set a $133.00 price target on shares of Addus HomeCare in a report on Tuesday, June 10th. Finally, JMP Securities restated a “market outperform” rating and set a $150.00 price target on shares of Addus HomeCare in a report on Tuesday, April 22nd. One research analyst has rated the stock with a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $142.57.
Addus HomeCare Trading Down 1.1%
Shares of Addus HomeCare stock opened at $112.80 on Monday. The stock has a fifty day simple moving average of $107.48 and a 200 day simple moving average of $112.11. Addus HomeCare Co. has a 12-month low of $88.96 and a 12-month high of $136.72. The company has a market capitalization of $2.08 billion, a P/E ratio of 25.81, a price-to-earnings-growth ratio of 1.41 and a beta of 0.81.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.09. The firm had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business’s revenue for the quarter was up 20.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.21 EPS. On average, analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current year.
Insider Transactions at Addus HomeCare
In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the sale, the executive vice president now owns 7,796 shares of the company’s stock, valued at approximately $896,540. This represents a 20.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 4.60% of the stock is owned by corporate insiders.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
See Also
- Five stocks we like better than Addus HomeCare
- CD Calculator: Certificate of Deposit Calculator
- RH Stock Rockets on Surprise Profit and Tariff Shift
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Alphabet Enters a Bull Market: Is It Time to Buy?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.